China Greenlights First Stem Cell Therapy On Mixed Clinical Findings
Supportive Regulatory Environment
China has granted its first approval for a stem cell therapy, to domestic firm Platinum Life Biotech’s umbilical cord-derived mesenchymal stem cell product for corticosteroid-failed acute graft-versus-host disease with gut involvement.
